Fortress Biotech, Inc.

Healthcare

NASDAQ:FBIO · NASDAQ Capital Market

Market Cap $98.59M Beta 1.16 P/E (TTM) 0.7

$2.93 +0.36%

+$0.01 today

52W Low $1.70High $4.53

Vol 0.37M · Avg 0.43M

EPS (TTM) $4.05Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+60.11%

Period High

$4.38

Period Low

$1.71

Latest

$2.93

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Relmada Therapeutics, Inc.

NASDAQ:RLMD

$487.67M

Immunic, Inc.

NASDAQ:IMUX

$136.78M

Vaxart, Inc.

NASDAQ:VXRT

$135.55M

Adagene Inc.

NASDAQ:ADAG

$134.41M

Gain Therapeutics, Inc.

NASDAQ:GANX

$71.66M

XBiotech Inc.

NASDAQ:XBIT

$71.34M

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

$59.20M

TScan Therapeutics, Inc.

NASDAQ:TCRX

$55.71M

Nutriband Inc.

NTRB

$41.21M

CervoMed Inc.

CRVO

$22.68M

What is the latest FBIO filing?

The latest filing shown is SC 13G/A dated May 15, 2026.

How many recent filings does FBIO have?

Intrinsic Alpha currently shows 20 recent filings for FBIO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.